Diagnostic and Treatment of Diabetes Mellitus in Patients with Human Immunodeficiency Virus Infection
The antiretroviral therapy led to a significant reduction of morbidity and mortality in patients infected with human immunodeficiency virus. However, the cardiometabolic changes of the treatment and the population aging resulted on increased complexity of care for the management of cardiovascular morbidities. The increase of insulin resistance and prevalence of type 2 diabetes mellitus in these patients is already known for some years, and, therefore, it is important to know the screening tests and how to manage this metabolic disease, as well as the pharmacological treatment. This article aims to review the diagnosis and treatment of diabetes mellitus in patients infected with human immunodeficiency virus, and also the drug interactions between antiretroviral therapy and antidiabetic drugs, since the literature is poor in this area that we consider useful in clinical practice.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors, when submitting this paper for publication, transfer to “Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo” the rights and copyrights of the article.